Successful treatment of epidermal growth factor receptor inhibitor-induced periungual inflammation with adapalene

Junichi Hachisuka; Kazuko Doi; Yoichi Moroi; Masutaka Furue

doi:10.1159/000329914

Successful treatment of epidermal growth factor receptor inhibitor-induced periungual inflammation with adapalene

Junichi Hachisuka, Kazuko Doi, Yoichi Moroi, Masutaka Furue

Surgery

Research output: Contribution to journal › Article › peer-review

11 Citations (Scopus)

Abstract

Epidermal growth factor receptor (EGFR) inhibitors are increasingly used for cancer treatment, but commonly carry dermatologic side effects. Periungual inflammation is a particularly painful condition that additionally worsens quality of life. In this paper, we report 3 cases of successful treatment of periungual inflammation induced by 3 different EGFR inhibitors (gefitinib, erlotinib, and cetuximab) with topically applied adapalene.

Original language	English
Pages (from-to)	130-136
Number of pages	7
Journal	Case Reports in Dermatology
Volume	3
Issue number	2
DOIs	https://doi.org/10.1159/000329914
Publication status	Published - May 2011

All Science Journal Classification (ASJC) codes

Dermatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1159/000329914

Cite this

@article{2812e01771c04080b243e589dd319a93,

title = "Successful treatment of epidermal growth factor receptor inhibitor-induced periungual inflammation with adapalene",

abstract = "Epidermal growth factor receptor (EGFR) inhibitors are increasingly used for cancer treatment, but commonly carry dermatologic side effects. Periungual inflammation is a particularly painful condition that additionally worsens quality of life. In this paper, we report 3 cases of successful treatment of periungual inflammation induced by 3 different EGFR inhibitors (gefitinib, erlotinib, and cetuximab) with topically applied adapalene.",

author = "Junichi Hachisuka and Kazuko Doi and Yoichi Moroi and Masutaka Furue",

year = "2011",

month = may,

doi = "10.1159/000329914",

language = "English",

volume = "3",

pages = "130--136",

journal = "Case Reports in Dermatology",

issn = "1662-6567",

publisher = "S. Karger AG",

number = "2",

}

TY - JOUR

T1 - Successful treatment of epidermal growth factor receptor inhibitor-induced periungual inflammation with adapalene

AU - Hachisuka, Junichi

AU - Doi, Kazuko

AU - Moroi, Yoichi

AU - Furue, Masutaka

PY - 2011/5

Y1 - 2011/5

N2 - Epidermal growth factor receptor (EGFR) inhibitors are increasingly used for cancer treatment, but commonly carry dermatologic side effects. Periungual inflammation is a particularly painful condition that additionally worsens quality of life. In this paper, we report 3 cases of successful treatment of periungual inflammation induced by 3 different EGFR inhibitors (gefitinib, erlotinib, and cetuximab) with topically applied adapalene.

AB - Epidermal growth factor receptor (EGFR) inhibitors are increasingly used for cancer treatment, but commonly carry dermatologic side effects. Periungual inflammation is a particularly painful condition that additionally worsens quality of life. In this paper, we report 3 cases of successful treatment of periungual inflammation induced by 3 different EGFR inhibitors (gefitinib, erlotinib, and cetuximab) with topically applied adapalene.

UR - http://www.scopus.com/inward/record.url?scp=80052761828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052761828&partnerID=8YFLogxK

U2 - 10.1159/000329914

DO - 10.1159/000329914

M3 - Article

C2 - 21743808

AN - SCOPUS:80052761828

SN - 1662-6567

VL - 3

SP - 130

EP - 136

JO - Case Reports in Dermatology

JF - Case Reports in Dermatology

IS - 2

ER -

Successful treatment of epidermal growth factor receptor inhibitor-induced periungual inflammation with adapalene

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this